EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative analysis of the efficacy and safety of antibody‑drug conjugates, radionuclide‑drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment

Huan Du, Xiao-Fei Hao, Bin-Wei Lin, Yu Zhang, Luo Rui, Jing Wang, Ming-Ming Tang, De-Cai Wang, Yi-Han Zhu, Jie Li, Tang-Zhi Dai, Yuchuan Yang und 2 weitere

Oncology Reports · 2025

DOI: 10.3892/or.2025.9009 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Oncology Reports, 2025. Verfasst von Huan Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan 621000, P.R. China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Immunoconjugates, Claudins, Radiopharmaceuticals. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsImmunoconjugatesClaudinsRadiopharmaceuticalsAnimalsHumansMiceXenograft Model Antitumor AssaysRadioisotopesCell Line, TumorTissue DistributionLutetiumFemaleAntibodies, MonoclonalZirconiumMale

Stichwörter der Autor:innen

177LuADCCLDN18.2SYSA1801gastric cancer

Substanzen

ImmunoconjugatesRadioisotopesClaudinsLutetiumCLDN18 protein, humanRadiopharmaceuticalsLutetium-177Antibodies, MonoclonalZirconiumZirconium-89

Autor:innen und Institutionen

  • Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan 621000, P.R. China.
  • Department of Nuclear Medicine, Central Hospital of Mianyang, Mianyang, Sichuan 621000, P.R. China.
  • Institute of Nuclear Physics and Chemistry, China Academy of Engineering Physics, Mianyang, Sichuan 621900, P.R. China.
  • Department of Clinical Medicine, Clinical Medical School, North Sichuan Medical College, Nanchong, Sichuan 637007, P.R. China.

Zitieren

APA

Du, H., Hao, X. F., Lin, B. W., Zhang, Y., Rui, L., Wang, J., Tang, M. M., Wang, D. C., Zhu, Y. H., Li, J., Dai, T. Z., Yang, Y., Yang, X., & Du, X. (2025). Comparative analysis of the efficacy and safety of antibody‑drug conjugates, radionuclide‑drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment. Oncology Reports. https://doi.org/10.3892/or.2025.9009

Vancouver

Du H, Hao XF, Lin BW, Zhang Y, Rui L, Wang J, et al. Comparative analysis of the efficacy and safety of antibody‑drug conjugates, radionuclide‑drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment. Oncology Reports. 2025. doi:10.3892/or.2025.9009

BibTeX
@article{Du2025,
  author = {Du, Huan and Hao, Xiao-Fei and Lin, Bin-Wei and Zhang, Yu and Rui, Luo and Wang, Jing and Tang, Ming-Ming and Wang, De-Cai and Zhu, Yi-Han and Li, Jie and Dai, Tang-Zhi and Yang, Yuchuan and Yang, Xia and Du, Xiaobo},
  title = {Comparative analysis of the efficacy and safety of antibody‑drug conjugates, radionuclide‑drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment},
  journal = {Oncology Reports},
  year = {2025},
  doi = {10.3892/or.2025.9009}
}
Kostenlos starten →